Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
168.49-1.22 (-0.72%)
As of 10:18 AM EDT. Market open.
People also watch:
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open170.39
Prev Close169.71
Bid169.03 x 100
Ask169.10 x 100
Day's Range168.24 - 170.39
52wk Range135.64 - 176.85
1y Target EstN/A
Market Cap126.09B
P/E Ratio (ttm)17.24
Beta1.34
Volume565,872
Avg Vol (3m)2,840,878
Dividend & Yield4.00 (2.33%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Reuters22 minutes ago

    Amgen, Arrowhead team up on gene-therapies for heart disease

    Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and collaborate with the company to develop gene-silencing therapies for heart disease. Arrowhead will get $35 million up front and a $21.5 million injection from Amgen that will give the world's No. 1 biotech company by market value an equity stake of 4.5 percent. Pasadena, California-based Arrowhead will also eligible for up to $617 million in further milestone and equity payments.

  • Amgen, Inc. breached its 50 day moving average in a Bearish Manner : AMGN-US : September 29, 2016
    Capital Cube2 hours ago

    Amgen, Inc. breached its 50 day moving average in a Bearish Manner : AMGN-US : September 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Amgen, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • MarketWatch2 hours ago

    Amgen and Arrowhead Pharma agree 2 cardiovascular collaborations

    Amgen Inc. and Arrowhead Pharmaceuticals Inc. said Thursday they have agreed to two cardiovascular collaborations. Under one agreement, Amgen will receive an exclusive license option to Arrowhead's proprietary ...